These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 20164921

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity.
    Lv Z, Williams KM, Yuan L, Atkison JH, Olsen SK.
    J Biol Chem; 2018 Nov 23; 293(47):18337-18352. PubMed ID: 30279270
    [Abstract] [Full Text] [Related]

  • 24. Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions.
    Liu B, Lois LM, Reverter D.
    Sci Rep; 2017 Feb 06; 7():41998. PubMed ID: 28165030
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Structural biology: Transformative encounters.
    Schulman BA, Haas AL.
    Nature; 2010 Feb 18; 463(7283):889-90. PubMed ID: 20164915
    [No Abstract] [Full Text] [Related]

  • 29. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
    Castaño-Miquel L, Seguí J, Manrique S, Teixeira I, Carretero-Paulet L, Atencio F, Lois LM.
    Mol Plant; 2013 Sep 18; 6(5):1646-60. PubMed ID: 23482370
    [Abstract] [Full Text] [Related]

  • 30. Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway.
    Duda DM, van Waardenburg RC, Borg LA, McGarity S, Nourse A, Waddell MB, Bjornsti MA, Schulman BA.
    J Mol Biol; 2007 Jun 08; 369(3):619-30. PubMed ID: 17475278
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A, Sailer C, Ryu S, Catone N, Stankovic-Valentin N, Schmidtke G, Melchior F, Stengel F, Groettrup M.
    Nat Commun; 2019 Oct 01; 10(1):4452. PubMed ID: 31575873
    [Abstract] [Full Text] [Related]

  • 33. Stability of thioester intermediates in ubiquitin-like modifications.
    Song J, Wang J, Jozwiak AA, Hu W, Swiderski PM, Chen Y.
    Protein Sci; 2009 Dec 01; 18(12):2492-9. PubMed ID: 19785004
    [Abstract] [Full Text] [Related]

  • 34. The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1.
    Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL, Holton JM, Schulman BA.
    Mol Cell; 2003 Dec 01; 12(6):1427-37. PubMed ID: 14690597
    [Abstract] [Full Text] [Related]

  • 35. Expression, purification, and crystal structure of N-terminal domains of human ubiquitin-activating enzyme (E1).
    Xie ST.
    Biosci Biotechnol Biochem; 2014 Dec 01; 78(9):1542-9. PubMed ID: 25209502
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D, Lima CD.
    Nature; 2005 Jun 02; 435(7042):687-92. PubMed ID: 15931224
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Systematic determinations of SUMOylation activation intermediates and dynamics by a sensitive and quantitative FRET assay.
    Song Y, Liao J.
    Mol Biosyst; 2012 Jun 02; 8(6):1723-9. PubMed ID: 22466055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.